巴克莱银行对Sagimet Biosciences Inc.的评级进行了重大调整,将其从"持平"上调至"增持"。
与此同时,该机构将Sagimet Biosciences的目标股价从原先的8美元大幅提升至18美元,这一调整幅度令人瞩目。
巴克莱银行对Sagimet Biosciences Inc.的评级进行了重大调整,将其从"持平"上调至"增持"。
与此同时,该机构将Sagimet Biosciences的目标股价从原先的8美元大幅提升至18美元,这一调整幅度令人瞩目。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.